Company Announcements

Publication of Factsheet

Source: RNS
RNS Number : 9449K
Hipgnosis Songs Fund Limited
23 December 2022
 

LEI: 213800XJIPNDVKXMOC11

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Publication of Factsheet

23 December 2022

Hipgnosis Songs Fund Limited has today published its factsheet for December 2022. Copies can be downloaded from the Company's website, www.hipgnosissongs.com/company-documents .

For further information please contact:

 

Hipgnosis Song Management

Merck Mercuriadis

Chris Helm

Giles Croot (Media)

Rufina Pavry (Investors)

 

 

 

 

 

+44 (0)20 4542 1511

+44 (0)20 4542 1530

Singer Capital Markets - Joint Corporate Broker

James Moat / James Maxwell / Alex Emslie (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 

+44 (0)20 7496 3000

J.P. Morgan Cazenove - Joint Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

James Bouverat (Sales)

+44 (0)20 7742 4000

RBC Capital Markets - Joint Corporate Broker

Elliot Thomas / Max Avison (Corporate Finance)

Lisa Tugwell / Anastasia Mikhailova (Sales)

+44 (0)20 7635 4000

Ocorian - Company Secretary & Administrator

Lorna Zimny

+44 (0) 28 9693 0222

The Outside Organisation

Alan Edwards / Nick Caley

+44 (0)7711 081 843

FTI Consulting

Neil Doyle / Paul Harris / Laura Ewart

+44 (0)7771 978220; +44 (0)7809 411882; +44 (0)7761 332646

All US music publicity enquiries

Fran Defeo

+1 917 767 5255


 



 

Notes to Editors

About Hipgnosis Songs Fund

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. The Company has raised a total of almost £1.3 billion (gross equity capital) through its Initial Public Offering on 11 July 2018, and subsequent issues in April 2019, August 2019, October 2019, July 2020, September 2020, February 2021 and July 2021. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premium segment of the Main Market, and in March 2020 became a constituent of the FTSE 250 Index. Since April 2021, the Company has been resident in the UK for tax purposes and is recognised as an investment trust under applicable HMRC regulations.

About Hipgnosis Song Management Limited

 

The Hipgnosis Songs Fund's Investment Adviser is Hipgnosis Song Management Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of Hipgnosis Song Management Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, David A. Stewart, Poo Bear, Bill Leibowitz, Ian Montone and Rodney Jerkins.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFELFVLVFIF